Royal Bank of Canada Increases Xylem (NYSE:XYL) Price Target to $162.00

Xylem (NYSE:XYL) had its price target lifted by Royal Bank of Canada from $157.00 to $162.00 in a research note issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the industrial products company’s stock. Royal Bank of Canada’s price objective points to a potential upside of 18.07% from the stock’s previous close.

XYL has been the topic of several other reports. Oppenheimer boosted their target price on Xylem from $142.00 to $147.00 and gave the company an “outperform” rating in a research note on Friday. BNP Paribas assumed coverage on Xylem in a research note on Tuesday, March 12th. They set an “outperform” rating and a $150.00 target price on the stock. Citigroup boosted their target price on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research note on Monday, April 8th. Stifel Nicolaus boosted their target price on Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. Finally, Raymond James raised Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $140.70.

Xylem Stock Performance

Shares of XYL stock opened at $137.21 on Friday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.30 and a current ratio of 1.67. Xylem has a fifty-two week low of $87.59 and a fifty-two week high of $138.46. The stock has a 50 day moving average price of $128.64 and a two-hundred day moving average price of $115.36. The company has a market capitalization of $33.26 billion, a P/E ratio of 48.83, a PEG ratio of 2.67 and a beta of 1.08.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The firm had revenue of $2.03 billion during the quarter, compared to the consensus estimate of $2 billion. During the same quarter in the previous year, the company posted $0.72 earnings per share. The business’s revenue was up 40.4% on a year-over-year basis. Analysts expect that Xylem will post 4.2 earnings per share for the current year.

Insider Buying and Selling

In other news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the sale, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the sale, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is owned by insiders.

Institutional Investors Weigh In On Xylem

A number of institutional investors have recently modified their holdings of XYL. Bruce G. Allen Investments LLC bought a new position in shares of Xylem during the fourth quarter valued at $27,000. NBC Securities Inc. bought a new position in shares of Xylem during the third quarter valued at $38,000. FinTrust Capital Advisors LLC lifted its holdings in shares of Xylem by 170.9% during the first quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock valued at $41,000 after purchasing an additional 200 shares in the last quarter. Hazlett Burt & Watson Inc. lifted its holdings in shares of Xylem by 184.9% during the first quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 220 shares in the last quarter. Finally, Orion Capital Management LLC bought a new position in shares of Xylem during the third quarter valued at $48,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.